IP Verse

Neymeyr competitive analysis

Explore patent oppositions filed by Neymeyr against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026

Patent Number	Title	Applicant	Opposition Date
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Dec 23, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 16, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 1, 2025
EP4097091	Solid State Forms Of Mavacamten And Process For Preparation Thereof	ASSIA CHEMICAL INDUSTRIES	Jun 17, 2025
EP4041186	An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis	LEO PHARMA	Feb 17, 2025
EP3373972	Compositions For Treating Spinal Muscular Atrophy	F HOFFMANN LA ROCHE	Dec 20, 2024
EP3820625	Device For Dispensing A Fluid Product, And Method For Filling And For Plugging Same	APTAR FRANCE	Dec 12, 2024
EP3626270	New Use	NOVARTIS	Jul 10, 2024
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Nov 30, 2023
EP3067043	Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor	NOVARTIS	Aug 24, 2023

Discover the latest PTAB cases involving Neymeyr, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Neymeyr with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DR SCHON	28	-	-	-
IT SEAL	-	2	-	-
NOVARTIS	6	424	-	21
NOVO NORDISK	8	109	1	9